Researchers conducting a Phase 2 clinical trial at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine say a new combination of antibody therapies produced a “surprisingly high” response rate in patients with high-risk follicular…
in Health
Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
